Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
Kunihiro Suzuki(Kyushu University), Yoichi Nakanishi(RIKEN Center for Integrative Medical Sciences)
Cited by 13
Related Papers
Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads
|The Journal of Immunology|2008|183
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
|Journal of Clinical Oncology|2016|160
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2015|86